Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

NCT03257644 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03257644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03257644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Completed
Start date
September 21, 2017
Completion date
October 7, 2020
Enrollment
70 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis